News and Events
Cell Bridge Strategies Sponsors “Regenerative Medicine and Cell Therapy – The India Landscape” Session at Virtual World Stem Cell Summit, June 6-11
Boerne, TX. June 1, 2022 — Cell Bridge Strategies, an industry thought leader and consulting firm for Regenerative Medicine and the Advanced Therapies announced its sponsorship and design of an executive-level panel session to address the significant impact India is having in Regenerative Medicine and Advanced Therapies at this year’s Regenerative Medicine Foundations (RMF) Virtual World Stem Cell Summit (WSCS) and Regenerative Medicine Essentials Course. The combined event will be broadcast June 6-11.
The session entitled, Regenerative Medicine and Cell Therapy – The India Landscape, is part of the WSCS’s regional and international showcases that provide attendees with key insights from industry leaders across geographic and institutional segments. Dr. Preveen Ramamoorthy Ph.D., Advisory Board Member & Principal Consultant for Cell Bridge Strategies, is a leader in precision medicine & global health, has organized and will chair the session. Dr. Ramamoorthy has been a critical contributor, collaborator, leader of numerous biopharmaceutical, healthcare ventures, and collaborations between India and US for the past two decades.
“India is front and center for innovations in Regenerative Medicine and the Advanced Therapies. As part of our efforts to breakdown silos, expand knowledge, and forge collaborations, the RMF is excited to share the expertise of Cell Bridge Strategies’ Dr. Preveen Ramamoorthy as he leads the discussion on the scientific and business drivers emerging from India, and how they play a key role in the advancement of our Industry,” said Bernard Siegel, RMF’s Executive Director.
RMF and Cell Bridge Strategies, are excited to present an entire series of talks, featuring the landscape of Regenerative Medicine and Cell Therapy in India at the World Stem Cell Summit for the first time. The goal of this India track is to catalyze collaborations between Indian industry, academia with their counterparts globally, and particularly between India and the USA. The speakers represent the wide breadth of the fast growing, India Regenerative Medicine and Cell Therapy ecosystem, ranging from academia, government policy, industry, key opinion leaders to entrepreneurs. The content of the India track covers the state of the regulatory, funding, talent, commercialization, infrastructure, scientific, clinical, manufacturing and government policy. Companies featured in our India track are working on cutting edge areas of Cell Therapy and Regenerative Medicine, with products in early-stage clinical development, in the areas of mesenchymal stem cells (MSCs), Chimeric antigen receptor (CAR) T-cells, Natural Killer (NK) cells and pluripotent stem cells (PSCs).
Regional and International Showcase Highlights. The India Market
- Regenerative Medicine and Cell Therapy – The India Landscape - Dr. Preveen Ramamoorthy – Cell Bridge Strategies, Ph.D., Session Chair
- Looking Beyond Challenges: A Perspective on Stem Cell Research in India – Dr. Maneesha Inamdar, JNU-inSTEM
- Translating Adult Stem Cell Technology into Real-time Applications – Dr. Suba Dravida CEO, Tran-Scell Biologics Pvt. Ltd and Uday Chatterjee, Angel Investor
- Commercializing a Cell Therapy Product in India – B.N. Manohar, MD & CEO, Stempeutics Research
- The Eyestem Proposition – Dr. Jogin Desai, Founder and CEO, Eyestem
- Regenerative Medicine and Cell Therapy – The India Landscape: Panel Presentation –
o Dr. Preveen Ramamoorthy – Cell Bridge Strategies, Moderator & Chair
o Dr. Renu Swarup – Former Secretary, Govt. of India, Dept. of Biotechnology, panel presentation participant
o Dr. Ram Mandalam – Citrabio Consulting, panel presentation participant
o Dr. Mahendra Rao – panCELLa & Implant Therapeutics, panel presentation participant
Dr. Jane Andrews, Cell Bridge Strategies’ Founder and CEO, shared, “We are very excited to sponsor the forum on how India is impacting advances in Regenerative Medicine and the Advanced Therapies at the World Stem Cell Summit 2022.” Dr. Andrews added, “As a global consulting firm we understand the complex convergence of technologies across regions that must occur to drive innovation. We are happy to share industry insights to accelerate communications so that innovation is transformed into curative medicines that ultimately treat patients.”
The Virtual World Stem Cell Summit is designed to breakdown silos, expand knowledge, and forge collaborations, with the goal of improving health and delivering cures. The nonprofit Regenerative Medicine Foundation has built the strongest, most comprehensive, and trusted global network for Regenerative Medicine, uniting the world’s leading researchers, medical centers, universities, labs, businesses, funders, policymakers, experts in law, regulation and ethics, medical philanthropies and patient organizations.
The Virtual World Stem Cell Summit will take place June 6-11. The full conference agenda and registrations can be found at https://www.worldstemcellsummit.com.
About Cell Bridge Strategies, LLC
Cell Bridge Strategies, LLC is an international growth consulting firm that helps Life Science and Advanced Therapy companies bridge science and business. Our team of experts, each with 20+ years of industry knowledge, guide executives through the challenges of commercialization, manufacturing, distribution, and regulatory through the development of strategy and tactics that optimize the match between your core assets and market opportunities. Let us help you succeed faster, with lower risk, and greater return on investment, and most importantly, cure patients. For more information, visit cellbridgestrategies.com.
About Regenerative Medicine Foundation
The nonprofit Regenerative Medicine Foundation fosters strategic collaborations to accelerate the development of regenerative medicine to improve health and deliver cures. RMF unites the world’s leading researchers, medical centers, universities, labs, businesses, funders, policymakers, experts in law, regulation and ethics, medical philanthropies, and patient organizations. RMF maintains a trusted network of leaders and pursues its mission by producing the flagship World Stem Cell Summit series of conferences and Public Days, honoring leaders through the Stem Cell and Regenerative Medicine Action Awards, promoting solution-focused policy initiatives both nationally and internationally and creating STEM/STEAM educational projects. For more information about RMF, please visit: www.regmedfoundation.org.